植耀輝: 美股急跌觀望議息 港股考驗21,000點支持
耀才證券研究部總監植耀輝稱,美股上周五(10日)急挫,美國5月CPI升至40年新高,反映通脹依然未受控,投資者憂慮聯儲局將採取更激進加息步伐。受此影響,美股三大指數均急挫,當中道指大跌880點或2.7%,標普500指數亦跌2.9%,納指跌幅更大,達到3.5%。全周計道指累跌4.6%,標普500指數及納指累跌更達到5.05%及5.6%。
港股方面,上周表現較為反覆,不過在新經濟股份支持下,恆指仍有不俗表現,全周計恆指累升724點或3.4%,收報21,806點。科指表現更強,累升近一成,收報4,826點。但更誇張的是有三隻藍籌一周累升超過兩成,分別為阿里健康(00241.HK)、阿里-SW(09988.HK)及藥明生物(02269.HK),升幅達到29%、22%及21%。值得一提的是,科技股整體亦有好表現,美團-W(03690.HK)及京東-SW(09618.HK)分別上升11.7%及13.3%,騰訊(00700.HK)升幅亦達到一成。除新經濟股外,汽車股亦造好,比亞迪(01211.HK)股價亦累升超過11%。
相比之下,內房股表現則令人失望,龍湖(00960.HK)成為上周最大跌幅藍籌,累跌超過11%,中海外(00688.HK)跌幅較輕微,但亦跌超過4%。至於四隻準藍籌,上周則個別發展,東方海外(00316.HK)受航運股大跌拖累,累跌11.6%,相反中芯(00981.HK)則急升近一成,另外中升(00881.HK)亦升2.6%,而中國宏橋(01378.HK)則僅微跌0.7%。至於被剔除之瑞聲(02018.HK)則上升2.4%。
由於美股上周五急挫,加上本周尚有聯儲局議息會議,相信港股今日(13日)難有好表現,當然若A股能表現能靠穩,則對港股或會有一定幫助,惟新經濟股今日或會顯著回調。短期暫看21,000點能否企穩。
(筆者為證監會持牌人,並未持有相關股份)
********
恆指將回試21,100點即20天線水平支持
耀才研究部稱,上周五(10日)美股急挫,美國5月份CPI按年升8.6%,高過預期及前值的0.3個百分點,再創逾40年新高,打破了通脹見頂的憧憬。本周三及四(15至16日)美聯儲將舉行重磅議息會議,市場認為此輪加息0.75厘的機會率更由9%升至29%,道指收市跌近900點。由於外圍氣氛轉弱,上周累積較多升幅的科網股將出現回吐,黑期預示恆指將於21,100點水平爭持,目前較關鍵為內地疫情的發展,因應北京及上海重現本土確診案例,內需股亦難以避免下跌,資金於市況不穩的情況下較大機會追入新能源及高息股避險。
技術上,恆指未能升穿100天線22,100點,即市支持為21400,若該水平未能守住,指數將回試21,100點水平,亦即恆指3月至4月於22,400至21,100點的區間底部。
(筆者為證監會持牌人)~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.